
2026-04-08
Ukwelashwa komdlavuza wamaphaphu kusenesikhathi ngo-2026 kubhekisa ekungeneleleni kwezokwelapha okuthuthukile okusetshenziselwa ukuthola nokuphatha umdlavuza wamaphaphu ezigabeni zawo zokuqala, okwenza ngcono kakhulu amazinga okusinda. Izindlela zamanje e-China futhi zihlanganisa emhlabeni wonke ubuhlakani bokwenziwa (AI) ukuze butholakale kusenesikhathi, amasu okuhlinza anembile, izindlela zokwelapha ezihlosiwe, kanye ne-immunotherapy. Iziguli ezifunayo ukwelashwa komdlavuza wamaphaphu kusenesikhathi manje ingakwazi ukufinyelela ezinhlelweni zokuhlola ezingabizi kakhulu, njengezikena ze-CT ezithuthukisiwe ze-AI ezitholakala ezibhedlela ezinkulu zaseShayina cishe ngama-dollar angu-25, ngokuhambisana nemithi yokwelapha esezingeni eliphezulu eyenza ukunakekelwa komuntu siqu okusekelwe kumaphrofayili ofuzo.
Umdlavuza wamaphaphu usalokhu uyimbangela ehamba phambili yokufa okuhlobene nomdlavuza emhlabeni wonke, kodwa isimo sezwe ukwelashwa komdlavuza wamaphaphu kusenesikhathi ishintshe kakhulu ngo-2026. Ushintsho olusuka endleleni yokulinganisa yonke ukuya emuthini onembayo luchaze kabusha imiphumela yesiguli. Ukutholwa kusenesikhathi manje sekuyisisekelo sokwelashwa okuphumelelayo, ngobuchwepheshe obusha obuvumela odokotela bakwazi ukuhlonza izimila ngaphambi kokuba kuvele izimpawu.
Incazelo yomdlavuza wamaphaphu wesigaba sangaphambi kwesikhathi ngokuvamile ihlanganisa Isigaba I kanye neSigaba II somdlavuza wamaphaphu ongewona omncane (NSCLC), lapho isimila senziwe sasendaweni futhi singasakazekelanga ezithweni ezikude. Ngo-2026, ukugxila akukhona kuphela ekususeni isimila kodwa ekuvimbeleni ukuphindeka ngokwelashwa kwe-adjuvant okuklanyelwe ukuguqulwa kofuzo okukhethekile kwesiguli.
Intuthuko yakamuva yenze kwaba nokwenzeka ukwelapha umdlavuza wamaphaphu njengesimo esingalapheki esikhundleni sokuxilongwa okubulalayo ezigulini eziningi. Ukuhlanganiswa kwe Ukuxilongwa okuqhutshwa yi-AI futhi ukuhlinzwa okungenasidingo esincane yehlise izikhathi zokululama futhi yathuthukisa ikhwalithi yokuphila ngemva kokwelashwa.
Enye yempumelelo ebaluleke kakhulu ngo-2026 ukwamukelwa okusabalele kwamamodeli we-AI ku-radiology. Lezi zinhlelo zihlaziya ukuskena okujwayelekile kwe-low-dose computed tomography (LDCT) ngokunemba okungakaze kubonwe ngaphambili, ukukhomba amaqhuqhuva acashile amehlo omuntu angase awageje.
E-China, izibhedlela ezifana ne-Ningbo University Affiliated Hospital ziye zafaka amamodeli e-AI athuthukiswe izikhungo zocwaningo ezifana ne-DAMO Academy. Lawa mamodeli ahlaziye amakhulu ezinkulungwane zama-CT scan, ahlaba umkhosi ngempumelelo umdlavuza we-pancreatic kanye namaphaphu ezigulini ezethula izimpawu ezingahlobene.
Lobu buchwepheshe bubaluleke kakhulu kumdlavuza wamaphaphu, lapho izinga lokusinda leminyaka emihlanu leqa lisuka ngaphansi kuka-10% ezigabeni zakamuva liye ngaphezu kwama-70% lapho litholwa kusenesikhathi. Ikhono lokwenza lokhu kuhlola ngengxenyana yezindleko ezivamile—ngezinye izikhathi eziphansi njengo-$25 ezinhlelweni zokuhlola—livuse intshisekelo yomhlaba wonke yokwamukela amamodeli afanayo.
I-China iye yavela njengesizinda somhlaba wonke sokunakekelwa komdlavuza wamaphaphu, okuhlanganisa amanani eziguli aphezulu nokwamukelwa kwezobuchwepheshe ngokushesha. Ziningi izikhungo ezihola phambili ukwelashwa komdlavuza wamaphaphu kusenesikhathi, ehlinzeka ngezinsiza ezisezingeni lomhlaba kanye nocwaningo lokuqala.
Lesi sibhedlela sitholakala e-Shanghai, lesi sibhedlela siyisizinda socwaningo nokwelashwa komdlavuza wamaphaphu. Isanda kwethula i-“2026 CACA Lung Cancer Full-Domain Popular Science Action,” okuhloswe ngayo ukuletha imibono yokuvikela, ukuhlola, ukuxilonga, ukwelashwa, kanye nokubuyisela emphakathini.
Umnyango we-Oncology kulesi sibhedlela, oholwa ngongoti abadumile njengoSolwazi Zhou Caicun, ugcizelela ukuthi umdlavuza wamaphaphu awusesona isifo esisodwa kodwa uyiqembu lezifo ezichazwa izakhi zofuzo ezahlukene. Le filosofi iqhuba izinqubo zokwelashwa eziqondene nomuntu.
Njengesibhedlela esiphambili sochwepheshe bomdlavuza, i-Fudan University Shanghai Cancer Center ihamba phambili ekusunguleni okusha kokuhlinza kanye nokuhlolwa komtholampilo. Isikhungo sidlala indima ebalulekile ekubuyekezeni imihlahlandlela kazwelonke, okuhlanganisa ne-“Little Red Book” yokulawulwa komdlavuza webele namaphaphu.
Lesi sikhungo saziwa ngokubambelela ngokuqinile emithini esekelwe ebufakazini kuyilapho sihlanganisa ngokushesha ama-ejenti okwelapha amasha ekusebenzeni komtholampilo. Amaqembu abo ahlukahlukene aqinisekisa ukuthi sonke isiguli sithola ukuhlolwa okuphelele okubandakanya odokotela abahlinzayo, odokotela abahlinzayo bezokwelapha, kanye nama-radiologists.
Ukuthola ukunakwa kwamazwe ngamazwe, lesi sibhedlela sibonisa amandla e-AI ekunakekelweni okujwayelekile. Isebenza njengendawo yokuhlola yemodeli ye-DAMO PANDA AI, ekhombisa ukuthi ubuchwepheshe bungavala kanjani igebe phakathi kokunakekelwa okukhethekile kanye nokuhlolwa kwezempilo okuvamile.
Iziguli lapha ziyazuza ekuhambeni komsebenzi okungenazihibe lapho izexwayiso ze-AI zicupha ukubuyekezwa kochwepheshe ngokushesha, okuqinisekisa ukuthi azikho izimpawu zakuqala zobubi ezinganakwa. Le modeli isetshenziswa ezibhedlela eziningi zomphakathi esifundeni sonke.
Ingxenye yezezimali yokunakekelwa kwezempilo iyinkinga ebalulekile ezigulini emhlabeni jikelele. Ngo-2026, ukwakheka kwezindleko ze ukwelashwa komdlavuza wamaphaphu kusenesikhathi kuyehluka kakhulu kuye ngezwe, ubuchwepheshe obusetshenziswayo, kanye nesigaba sokutholwa.
Izindlela zokuhlola zendabuko emazweni aseNtshonalanga zingabiza kakhulu, ngokuvamile zibiza amakhulukhulu amadola nge-CT scan eyodwa. Kodwa-ke, ukuhlanganiswa kwe-AI e-China kuphazamise le modeli.
Izinhlelo zokuhlola ezisebenzisa i-AI-enhanced flat-scan CTs zehlise izindleko zokuhlola zafinyelela cishe cishe $25 USD. Lokhu kwehliswa okukhulu kufezwa ngokusebenzisa:
Lokhu kufinyeleleka kwenza ukuhlola okuvamile kwenzeke kumanani abantu abaningi, okungenzeka kuguqule ijika lokuxilonga liye ezigabeni zangaphambili lapho ukwelashwa kungangeneleli futhi kubiza kancane.
Nakuba ukuhlola sekufinyeleleke kakhulu, izindleko zokwelashwa okuqinisekile zincike endleleni ekhethiwe. Ukuhlinzwa kabusha, indinganiso eyigolide yomdlavuza wamaphaphu wesigaba sokuqala, kuhilela ukuhlala esibhedlela, ukulaliswa kwezinzwa, kanye nezindleko zikadokotela ohlinzayo.
E-China, izindleko eziphelele zokuhlinzwa kwethoracoscopic okusizwa ngevidiyo kancane (i-VATS) zingasuka ku-$3,000 ziye ku-$8,000, ziphansi kakhulu kunezinqubo eziqhathanisekayo e-US noma eYurophu. Lokhu kuhlanganisa ukuhlolwa kwangaphambi kokuhlinzwa nokunakekelwa kwangemva kokuhlinzwa.
Ezigulini ezidinga ukwelashwa kwe-adjuvant, izindleko ziyahlukahluka kuye ngemithi esetshenzisiwe. Ukwelapha ngamakhemikhali endabuko ngokuvamile akubizi, kuyilapho izindlela zokwelapha ezihlosiwe ezintsha kanye nama-immunotherapies kungase kubize kakhulu. Kodwa-ke, izinhlelo zomshwalense kazwelonke kanye nezinqubomgomo zokuthengwa kwempahla ngobuningi e-China zehlise kakhulu izindleko eziphuma ephaketheni zale mithi ethuthukisiwe.
| Isakhi | Izindleko Ezilinganiselwe e-China (USD) | Izindleko Ezilinganiselwe e-USA (USD) | Amanothi |
|---|---|---|---|
| Ukuhlolwa Kwe-LDCT Okuthuthukisiwe kwe-AI | $25 - $60 | $300 - $800 | I-China isebenzisa i-AI ekusebenzeni kahle kokuhlolwa okukhulu. |
| Ukuhlinzwa Kwe-VATS (Isigaba Sasekuqaleni) | $3,000 - $8,000 | $20,000 – $50,000+ | Kubandakanya ukuhlala esibhedlela nokunakekelwa okuyisisekelo. |
| Ukwelapha Okuhlosiwe (Nyanga zonke) | $500 - $2,000 | $10,000 - $15,000 | Izintengo ziyahlukahluka ngezidakamizwa ezithile kanye nomshuwalense. |
| I-Immunotherapy (Ngomjikelezo ngamunye) | $1,000 - $3,000 | $12,000 - $20,000 | Ukuthenga ngenqwaba kunciphisa izindleko e-China. |
Leli thebula ligqamisa umehluko omkhulu kwezomnotho wezokunakekelwa kwempilo. Ngenkathi ikhwalithi yokunakekelwa ezibhedlela eziphezulu zaseShayina iphikisana neyaseNtshonalanga, inzuzo yezindleko yenza ukwelashwa komdlavuza wamaphaphu kusenesikhathi kufinyeleleke kakhudlwana esakhamuzini esivamile.
Izikhali ezilwa nomdlavuza wamaphaphu zikhule kakhulu. Ngo-2026, ukwelashwa akusapheleli ekuhlinzeni nasekwelapheni ngamakhemikhali. Uhlu lwemithi enembile lunikeza ithemba ngisho nasezimweni eziyinkimbinkimbi.
Ukuqonda ukwakheka kofuzo lwesimila manje sekuyingxenye evamile yenqubo yokuxilonga. Abashayeli abanjengo-EGFR, ALK, ROS1, kanye ne-KRAS banquma ukukhetha indlela yokwelapha.
Isizukulwane sesithathu se-EGFR tyrosine kinase inhibitors (TKIs) izinga lokunakekelwa kwe-EGFR-mutated NSCLC. Nokho, ukuphikiswa kuyakhula nakanjani. Ukuphumelela kwakamuva kubhekana ngqo nale nselele.
Ama-ADC amele ushintsho lwepharadigm ku-oncology. Lawa “mabhomu ahlakaniphile” aletha ukwelapha ngamakhemikhali okunamandla ngokuqondile kumaseli omdlavuza, konga izicubu ezinempilo. Ngo-2026, ama-ADC aqondise ku-TROP2 abonise ukusebenza kahle okumangalisayo ezigulini ezithuthuke kuma-EGFR-TKIs.
Izivivinyo zemitholampilo, ezifana nocwaningo lwe-OptiTROP-Lung04 oluholwa abacwaningi baseShayina, lubonise ukuthi ama-ADC aqondiswe ku-TROP2 anganweba kakhulu ukusinda okungenanqubekela phambili uma kuqhathaniswa nokwelashwa ngamakhemikhali okujwayelekile. Lokhu sekusungule izinga elisha lokunakekelwa kwamacala angazweli.
Ama-immune checkpoint inhibitors (ICIs) ayaqhubeka nokuba yisisekelo, kodwa igagasi elilandelayo lihlanganisa amasosha omzimba ahlanganisa amasosha omzimba ngempumelelo kakhulu. Le mithi ingakhomba ama-antigen amabili ahlukene ngesikhathi esisodwa, ithuthukise ukusabela komzimba ngokumelene nesimila.
Ezigulini ezisakhula, i-neoadjuvant immunotherapy (enikezwa ngaphambi kokuhlinzwa) ithola amandla. Ucwaningo luphakamisa ukuthi le ndlela inganciphisa amathumba, yenze ukuhlinzwa kube lula futhi kunciphise nengozi yokuphinda.
Yize kusesesimeni socwaningo lwemitholampilo, izindlela zokwelapha zamaseli ezifana ne-CAR-T zisahlolwa amathumba aqinile okuhlanganisa nomdlavuza wamaphaphu. Ukwengeza, imigomo yomuntu siqu yomdlavuza eklanyelwe i-neoantigens ehlukile yesiguli ibonisa isithembiso ekuvimbeleni ukuphindeka ngemva kokuhlinzwa.
Ukuzulazula ohlelweni lokunakekelwa kwezempilo kungase kube nzima. Kulabo abafuna ukwelashwa komdlavuza wamaphaphu kusenesikhathi, ikakhulukazi ezifundeni ezinamakhono athuthukile njenge-China, ukulandela indlela ehlelekile kuqinisekisa imiphumela engcono kakhulu.
Le ndlela ehlelekile yandisa amathuba okwelapha futhi inciphisa ukungenelela okungadingekile.
Ukukhetha indlela yokwelapha efanele kudinga ukuqonda okuhle nokubi kwezinketho ezitholakalayo. Ngezansi ukuqhathanisa amasu ayisisekelo asetshenziswa ngo-2026 kumdlavuza wamaphaphu osaqala.
| Indlela Yokwelapha | Izimpawu Ezisemqoka | Abakhethiwe Abakahle | Okuhle nokubi |
|---|---|---|---|
| Ukukhishwa kabusha Kokuhlinzwa (i-VATS/Amarobhothi) | Ukususwa ngokomzimba kwesimila kusetshenziswa amasu ahlasela kancane. | Iziguli ezine-Stage I-II NSCLC nomsebenzi omuhle wamaphaphu. | Okuhle: Ukwelashwa okungenzeka, ukususwa kwesimila ngokushesha. Ububi: Izingozi zokuhlinzwa, isikhathi sokululama, asifanele abantu abahlinzayo abampofu. |
| Ukwelapha Okuhlosiwe | Imithi yomlomo eqondise ekuguqukeni kofuzo okuthile (isb., EGFR, ALK). | Iziguli ezinezinguquko ezihlonziwe zabashayeli; ngokuvamile isetshenziswa njenge-adjuvant noma i-neoadjuvant. | Okuhle: Ukusebenza kahle okuphezulu, ukuphathwa ngomlomo, imiphumela emibi embalwa kune-chemo. Ububi: Ukuthuthukiswa kokumelana ngokuhamba kwesikhathi, kudinga ukuhlolwa kofuzo. |
| I-Immunotherapy | Izidakamizwa ezithuthukisa amasosha omzimba ukulwa nomdlavuza. | Iziguli ezinenkulumo ephezulu ye-PD-L1 noma njengengxenye yokwelashwa okuhlangene. | Okuhle: Izimpendulo ezihlala isikhathi eside, ezingase zibe khona ukuxolelwa kwesikhathi eside. Ububi: Izehlakalo ezimbi ezihlobene namasosha omzimba, amazinga okuphendula aguquguqukayo. |
| Ama-Antibody-Drug Conjugates (ADCs) | Ukulethwa okuhlosiwe kwama-ejenti e-chemotherapy kumaseli omdlavuza. | Iziguli ezinesifo esingazweli noma inkulumo ethize ye-antigen (isb., TROP2). | Okuhle: Ukuqondisa okunembayo, okusebenzayo ezimeni ezimelana nazo. Ububi: Amaphrofayela athile anobuthi (isb., i-neutropenia), idatha yesikhathi eside evelayo. |
Lokhu kuqhathanisa kugcizelela ukubaluleka komuthi womuntu siqu. Akukho ukwelashwa okukodwa “okungcono kakhulu”; ukukhetha okuhle kuncike kuphrofayili yomuntu yebhayoloji kanye nesimo somtholampilo.
Naphezu kwenqubekelaphambili emangalisayo, izinselele zisekhona ekulweni nomdlavuza wamaphaphu. Umehluko ekufinyeleleni ukwelashwa komdlavuza wamaphaphu kusenesikhathi phakathi kwezindawo zasemadolobheni nezasemaphandleni, naphakathi kwamazwe ahlukene, kuyisithiyo esikhulu.
Nakuba i-AI inikeza isixazululo, ukusatshalaliswa kwayo kabanzi kudinga ingqalasizinda nokuqeqeshwa. Izifunda eziningi zisantula izinsiza zokubala noma abasebenzi abanamakhono ukuze batolike imiphumela ye-AI ngempumelelo. Imizamo iyaqhubeka yokwenza lawa mathuluzi abe lula futhi ahlanganiswe emishinini ephathekayo yezindawo ezikude.
Imikhankaso yezemfundo, njengaleyo eyethulwe yi-China Anti-Cancer Association, ibalulekile. Bahlose ukuqwashisa umphakathi ngokubaluleka kokuhlolwa nokuqeda izinganekwane mayelana nokuxilongwa komdlavuza.
Ukungagwemeki kokumelana nezidakamizwa kusalokhu kuyimbangi enkulu. Abacwaningi bahlala behlola izinhloso ezintsha nezindlela ezihlanganisiwe zokuhlala ngaphambi kokuvela kwama-tumor clones. Kugxilwe kugxile “ekwelapheni okuguquguqukayo,” lapho ukwelashwa kulungiswa ngokuguquguqukayo ngokusekelwe ekuqashweni kwesikhathi sangempela kokuphendula kwesimila.
Ukuqoqwa kwenani elikhulu ledatha yomtholampilo kushayela igagasi elilandelayo lokutholwa. Ubufakazi bomhlaba wangempela (RWE) buhambisana nokuhlola okulawulwa ngokungahleliwe ngokunikeza imininingwane yokuthi ukwelapha kusebenza kanjani kuzilungiselelo ezihlukahlukene, zansuku zonke. Le datha ibalulekile ekucwengisiseni imihlahlandlela kanye nokuthuthukisa izinqubo zokwelapha.
Ukuze uqhubeke usiza abafundi, nazi izimpendulo zemibuzo evamile mayelana ukwelashwa komdlavuza wamaphaphu kusenesikhathi endaweni yamanje yezokwelapha.
Yebo, umdlavuza wamaphaphu wesigaba sokuqala (Isigaba I kanye nesesi-II) unezinga eliphezulu lokwelapha, ikakhulukazi uma welashwa ngokuhlinzwa okulandelwa ukwelashwa okufanele kwe-adjuvant. Izinga lokusinda leminyaka emihlanu leSiteji IA NSCLC lingadlula ama-80-90% ngezinqubo zokwelapha zesimanjemanje.
Ezinhlelweni zokuhlola e-China, ukuhlolwa kwe-CT okuthuthukisiwe kwe-AI kungabiza kancane njenge-$25. Kwezinye izingxenye zomhlaba, izindleko ziyahlukahluka kuye ngesistimu yokunakekelwa kwezempilo, ukuhlinzekwa komshwalense, kanye nobuchwepheshe obuthile obusetshenziswayo. Ngokuvamile, ishibhile kakhulu kunokuhlola okuphindaphindiwe okungokwesiko ngenxa yokunemba okuphezulu.
Imiphumela engemihle iyahluka ngokwesigaba sezidakamizwa. Izindlela zokwelapha ezihlosiwe ngokuvamile zibangela ukuqubuka kwesikhumba, isifo sohudo, noma ukuphakama kwama-enzyme esibindi. I-Immunotherapies ingaholela ezenzakalweni ezimbi ezihlobene nokuzivikela komzimba ezithinta amaphaphu, ikholoni, noma izindlala ze-endocrine. Ama-ADC angabangela i-neutropenia noma ukukhathala. Imiphumela emibi eminingi iyalawuleka ngokugadwa okufanele kwezokwelapha.
Yebo, izibhedlela eziningi ezisezingeni eliphezulu eChina, njengalezo eziseShanghai naseBeijing, zineminyango yamazwe ngamazwe enakekela iziguli zakwamanye amazwe. Bahlinzeka ngezinsizakalo eziphelele ezihlanganisa ukuhumusha, usizo lwe-visa, nezinhlelo zokwelashwa eziklanyelwe. Ukusebenza kahle kwezindleko kanye nobuchwepheshe obuthuthukile kwenza iShayina ibe indawo ekhangayo kwezokuvakasha kwezokwelapha ku-oncology.
Unyaka wezi-2026 umaka isikhathi esibalulekile emlandweni we- ukwelashwa komdlavuza wamaphaphu kusenesikhathi. Ukuhlangana kobuhlakani bokwenziwa, imithi enembayo, kanye nemithi yokwelapha emisha kuphendule lokho okwake kwaba yisigwebo sentambo kwaba isimo esilawulekayo, nesivame ukulapheka.
Kusukela ezibhedlela eziphithizelayo zase-Shanghai kuya emitholampilo yomphakathi ehlome nge-AI, umphakathi wezokwelapha emhlabeni wonke ubumbene emgomweni wawo wokuthola umdlavuza wamaphaphu kusenesikhathi futhi uwalaphe ngempumelelo. Ukwehliswa okumangalisayo kwezindleko zokuhlola kanye nokuba khona kokwelashwa okuyinkimbinkimbi njengama-ADC kanye namasosha omzimba akhethekile kunikeza ithemba elivuselelwe ezigidini.
Ezigulini nasemindenini, umyalezo ucacile: ukutholwa kusenesikhathi kusindisa izimpilo. Ukwamukela ubuchwepheshe obusha nokuthobela imihlahlandlela yokuhlola kuyizinyathelo ezinamandla kakhulu umuntu angazithatha. Njengoba ucwaningo luqhubeka nokuphusha imingcele, ikusasa lokunakekelwa komdlavuza wamaphaphu libukeka liqhakazile kunangaphambili, lithembisa izimpilo ezinde kanye nezinga lempilo elingcono kubo bonke abathintekile.
Kungakhathaliseki ukuthi ucabangela izinketho zokuhlola, ukuhlola izikhungo zokwelashwa, noma ufuna izindlela zokwelapha zakamuva, izinsiza nentuthuko etholakala ngo-2026 ihlinzeka ngesisekelo esiqinile sokulwa nalesi sifo. Hlala unolwazi, thatha isinyathelo kusenesikhathi, futhi usebenzise amandla emithi yesimanje ukuze uthole umphumela ongcono kakhulu ongakhona.